Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

This study is to describe the safety and efficacy of Xyntha® during the usual care setting.

Pfizer

Factor VIII